An examination of the Boston Naming Test: Calculation of "estimated" 60-item score from 30- and 15-item scores in a cognitively impaired population

Valerie L. Hobson, James Hall, Michelle Harvey, C. Munro Cullum, Laura Lacritz, Paul J. Massman, Stephen C. Waring, Sidney O'Bryant

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objective: Multiple versions of the Boston Naming Test (BNT) exist, which makes comparison of findings from different studies difficult. The current project sought to determine if estimated 60-item BNT scores could be reliably calculated from 30- and 15-item administrations with patients diagnosed with Alzheimer's disease (AD). Methods: Estimated 60-item scores were created for 30-item (even and odd) and 15-item Consortium to Establish a Registry for Alzheimer's disease (CERAD) versions of the BNT from a database containing item-level responses for all BNT items. Correlations were conducted between all three estimated 60-item scores and full 60-item version scores administered to all participants in the sample. Results: The estimated versions were all highly correlated with the standard 60-item version of the BNT across the sample and these findings held when the sample was separated out by case (AD) and control status. Mean difference scores were very small for scores estimated from 30-item administrations; however, difference scores for the 15-item CERAD were much larger. Conclusions: Estimated 60-item versions of the BNT can be created from 30-item BNT administrations, which will enable comparisons across studies and allow integration of data from various AD research groups for increased power in analytic protocols. Creation of an estimated score from the 15-item CERAD version is not warranted.

Original languageEnglish
Pages (from-to)351-355
Number of pages5
JournalInternational Journal of Geriatric Psychiatry
Volume26
Issue number4
DOIs
StatePublished - 1 Apr 2011

Fingerprint

Alzheimer Disease
Population
Registries
Databases
Research

Keywords

  • Alzheimer's disease
  • Boston naming test
  • CERAD
  • Neuropsychological testing

Cite this

Hobson, Valerie L. ; Hall, James ; Harvey, Michelle ; Cullum, C. Munro ; Lacritz, Laura ; Massman, Paul J. ; Waring, Stephen C. ; O'Bryant, Sidney. / An examination of the Boston Naming Test : Calculation of "estimated" 60-item score from 30- and 15-item scores in a cognitively impaired population. In: International Journal of Geriatric Psychiatry. 2011 ; Vol. 26, No. 4. pp. 351-355.
@article{92bab9442705439b95dbf6977a35919c,
title = "An examination of the Boston Naming Test: Calculation of {"}estimated{"} 60-item score from 30- and 15-item scores in a cognitively impaired population",
abstract = "Objective: Multiple versions of the Boston Naming Test (BNT) exist, which makes comparison of findings from different studies difficult. The current project sought to determine if estimated 60-item BNT scores could be reliably calculated from 30- and 15-item administrations with patients diagnosed with Alzheimer's disease (AD). Methods: Estimated 60-item scores were created for 30-item (even and odd) and 15-item Consortium to Establish a Registry for Alzheimer's disease (CERAD) versions of the BNT from a database containing item-level responses for all BNT items. Correlations were conducted between all three estimated 60-item scores and full 60-item version scores administered to all participants in the sample. Results: The estimated versions were all highly correlated with the standard 60-item version of the BNT across the sample and these findings held when the sample was separated out by case (AD) and control status. Mean difference scores were very small for scores estimated from 30-item administrations; however, difference scores for the 15-item CERAD were much larger. Conclusions: Estimated 60-item versions of the BNT can be created from 30-item BNT administrations, which will enable comparisons across studies and allow integration of data from various AD research groups for increased power in analytic protocols. Creation of an estimated score from the 15-item CERAD version is not warranted.",
keywords = "Alzheimer's disease, Boston naming test, CERAD, Neuropsychological testing",
author = "Hobson, {Valerie L.} and James Hall and Michelle Harvey and Cullum, {C. Munro} and Laura Lacritz and Massman, {Paul J.} and Waring, {Stephen C.} and Sidney O'Bryant",
year = "2011",
month = "4",
day = "1",
doi = "10.1002/gps.2533",
language = "English",
volume = "26",
pages = "351--355",
journal = "International Journal of Geriatric Psychiatry",
issn = "0885-6230",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

An examination of the Boston Naming Test : Calculation of "estimated" 60-item score from 30- and 15-item scores in a cognitively impaired population. / Hobson, Valerie L.; Hall, James; Harvey, Michelle; Cullum, C. Munro; Lacritz, Laura; Massman, Paul J.; Waring, Stephen C.; O'Bryant, Sidney.

In: International Journal of Geriatric Psychiatry, Vol. 26, No. 4, 01.04.2011, p. 351-355.

Research output: Contribution to journalArticle

TY - JOUR

T1 - An examination of the Boston Naming Test

T2 - Calculation of "estimated" 60-item score from 30- and 15-item scores in a cognitively impaired population

AU - Hobson, Valerie L.

AU - Hall, James

AU - Harvey, Michelle

AU - Cullum, C. Munro

AU - Lacritz, Laura

AU - Massman, Paul J.

AU - Waring, Stephen C.

AU - O'Bryant, Sidney

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Objective: Multiple versions of the Boston Naming Test (BNT) exist, which makes comparison of findings from different studies difficult. The current project sought to determine if estimated 60-item BNT scores could be reliably calculated from 30- and 15-item administrations with patients diagnosed with Alzheimer's disease (AD). Methods: Estimated 60-item scores were created for 30-item (even and odd) and 15-item Consortium to Establish a Registry for Alzheimer's disease (CERAD) versions of the BNT from a database containing item-level responses for all BNT items. Correlations were conducted between all three estimated 60-item scores and full 60-item version scores administered to all participants in the sample. Results: The estimated versions were all highly correlated with the standard 60-item version of the BNT across the sample and these findings held when the sample was separated out by case (AD) and control status. Mean difference scores were very small for scores estimated from 30-item administrations; however, difference scores for the 15-item CERAD were much larger. Conclusions: Estimated 60-item versions of the BNT can be created from 30-item BNT administrations, which will enable comparisons across studies and allow integration of data from various AD research groups for increased power in analytic protocols. Creation of an estimated score from the 15-item CERAD version is not warranted.

AB - Objective: Multiple versions of the Boston Naming Test (BNT) exist, which makes comparison of findings from different studies difficult. The current project sought to determine if estimated 60-item BNT scores could be reliably calculated from 30- and 15-item administrations with patients diagnosed with Alzheimer's disease (AD). Methods: Estimated 60-item scores were created for 30-item (even and odd) and 15-item Consortium to Establish a Registry for Alzheimer's disease (CERAD) versions of the BNT from a database containing item-level responses for all BNT items. Correlations were conducted between all three estimated 60-item scores and full 60-item version scores administered to all participants in the sample. Results: The estimated versions were all highly correlated with the standard 60-item version of the BNT across the sample and these findings held when the sample was separated out by case (AD) and control status. Mean difference scores were very small for scores estimated from 30-item administrations; however, difference scores for the 15-item CERAD were much larger. Conclusions: Estimated 60-item versions of the BNT can be created from 30-item BNT administrations, which will enable comparisons across studies and allow integration of data from various AD research groups for increased power in analytic protocols. Creation of an estimated score from the 15-item CERAD version is not warranted.

KW - Alzheimer's disease

KW - Boston naming test

KW - CERAD

KW - Neuropsychological testing

UR - http://www.scopus.com/inward/record.url?scp=79952748130&partnerID=8YFLogxK

U2 - 10.1002/gps.2533

DO - 10.1002/gps.2533

M3 - Article

C2 - 20690129

AN - SCOPUS:79952748130

VL - 26

SP - 351

EP - 355

JO - International Journal of Geriatric Psychiatry

JF - International Journal of Geriatric Psychiatry

SN - 0885-6230

IS - 4

ER -